POSEIDON study: A prospective, randomized, single-center study comparing a sliding-scale hydration strategy for the prevention of contrast-induced nephropathy.

Background: Contrast-induced nephropathy has been the subject of many studies not only because of the morbidity associated with prolonged hospital stay, (with dialysis requirement in some cases), but also with an increase in mortality in these patients. The preventive strategy hydration with saline solution 0.9% NaCl is the choice. However, the infusion rate and total time of hydration remains controversial.

Methods and results: The study was performed in a single U.S. tertiary center, it randomized evaluated patients undergoing coronary angiography with an estimated creatinine clearance of <60ml/min, (by MDRD), and at least another risk factor for contrast nephropathy, (diabetes, age over 75 years, history of hypertension and heart failure). It excluded patients who had been exposed to contrast in the past 48 hours, carriers of severe valvular disease, congestive heart failure, primary angioplasty, and increased creatinine levels above 15% in the two days prior to the procedure.

Patients received 3ml/kg infusion of SF 0.9% one hour before the procedure. During the procedure they were selected according to two strategies to prevent acute injury iodinated contrast: one guided by the end-diastolic pressure of left ventricle evaluated (LVEDP) in the cath lab by placing a pigtail catheter in the left ventricle, (LVEDP ≤ 13mmHg was administered 5ml/kg/h, LVEDP 13-18mmHg, 3ml/kg/h, and LVEDP> 18, 1.5 ml / kg / h), and another consisting of the conventional infusion SF 0.9% (1.5 ml / kg / h). After the procedure, both groups received the same scheme infusion for 4 hours. There were no differences between the groups in terms of baseline characteristics.

The primary endpoint, (incidence of CIN), was 6.7% in the group led by LVEDP and 16.3% in the control group, (p = 0.005). Hydration volume was 1,711ml administered to the LVEDP group versus 807 for the control group, (p <0.001). There was no difference in clinical outcomes considered: Death (0% versus 1.5%, p = 0.25), stroke (0.5% versus 2%, p = 0.37) and the need for dialysis (0.5% vs. 1.5%, p = 0.62) in guided groups, LVEDP and control respectively. In patients who had a kidney injury by contrast in their evolution the probability of dialysis was 10% of cases and death in 5% of patients. The hydration had to be suspended in 1.5% of cases in each group.

Conclusions: LVEDP guided hydration resulted in a relative reduction of 59%, (10% absolute reduction), in the incidence of acute kidney injury induced by contrast media. This is a safe and effective strategy. 

6_somjot_brar
Somjot Brar
2012-10-25

Original title: A Prospective, Randomized Trial of Sliding-Scale Hydration for Prevention of Contrast Nephropathy. POSEIDON study

 

More articles by this author

PC Trial: Clinical treatment or closure of patent foramen oval in cryptogenic stroke patients?

Background: The association between paradoxical embolism, including cryptogenic stroke, and the presence of patent foramen oval (PFO) has been found in previous clinical studies....

RESPECT: Randomized clinical trial evaluated the patent foramen oval closure vs clinical treatment in patients with cryptogenic stroke

Fundamentals: Etiology of cryptogenic stroke stills a major challenge for medicine. Paradoxical embolism remains one of the possible causes. Undoubtedly, adults between 20 and...

ADAPT-DES: Results at 1 year of the clinical impact of hypo-responders to aspirin and clopidogrel.

Background: The ADAPT-DES registry showed a strong correlation between hypo-responders to clopidogrel and the likelihood of stent thrombosis at 30 days, while the impact...

POST trial: Post-conditioning effect in myocardial reperfusion with primary angioplasty.

Ischemic postconditioning obtained through reversible ischemia and reproduced during reperfusion after a prolonged ischemic injury has shown comparable effects to ischemic preconditioning in preclinical...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...